• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病患者的健康相关生活质量和地中海饮食对肝纤维化的影响。

Impact of Health Related QoL and Mediterranean Diet on Liver Fibrosis in Patients with NAFLD.

机构信息

Department of Medical Sciences, University of Turin, 10126 Turin, Italy.

Metabolic Liver Disease Research Program, I. Department of Medicine, University Medical Center of the Johannes Gutenberg-University, 55131 Mainz, Germany.

出版信息

Nutrients. 2023 Jul 2;15(13):3018. doi: 10.3390/nu15133018.

DOI:10.3390/nu15133018
PMID:37447344
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10346905/
Abstract

Patients with non-alcoholic fatty liver disease (NAFLD) display impaired health-related quality of life (HRQoL) that is often linked to an unhealthy dietary pattern. The aim of this work was to investigate the impact of HRQoL and adherence to the Mediterranean diet on the risk of liver fibrosis (LF) in patients with NAFLD. LF was assessed in 244 patients through transient elastography (FibroScan530. Echosens, Paris, France). Significant LF was defined according to liver stiffness measurements (LSM) values ≥ 7.1 kPa. The Mediterranean diet score and the Short Form-36 questionnaires were also completed. The median age was 54 (44-62) years and 57% of participants were male. A total of 42 (17.2%) participants had LSM ≥ 7.1 kPa and showed increased GGT ( = 0.001), glucose ( < 0.001), and triglycerides levels ( = 0.015) compared to those with LSM ≤7.0 kPa. Moreover, patients with significant LF had significantly lower scores related to Physical Functioning ( < 0.001) and Role Physical ( < 0.001). In the logistic regression analysis, lower role physical and lower adherence to the MedDiet ( = 0.001 and = 0.009, respectively), after adjusting for age, diabetes, and obstructive sleep apnea, were associated with an increased risk of significant LF. Low adherence to MedDiet and low role physical may influence the risk of significant liver fibrosis in patients with NAFLD.

摘要

非酒精性脂肪性肝病 (NAFLD) 患者的健康相关生活质量 (HRQoL) 受损,这往往与不健康的饮食模式有关。本研究旨在探讨 HRQoL 和对地中海饮食的依从性对 NAFLD 患者肝纤维化 (LF) 风险的影响。通过瞬时弹性成像 (FibroScan530. Echosens, Paris, France) 评估 244 例患者的 LF。根据肝硬度测量值 (LSM) 值≥7.1 kPa 定义显著 LF。还完成了地中海饮食评分和简短形式 36 问卷。中位年龄为 54(44-62)岁,57%的参与者为男性。共有 42 名(17.2%)参与者的 LSM≥7.1 kPa,与 LSM≤7.0 kPa 的参与者相比,GGT( = 0.001)、血糖( < 0.001)和甘油三酯水平( = 0.015)升高。此外,LF 显著患者的生理机能( < 0.001)和生理职能( < 0.001)评分显著降低。在逻辑回归分析中,调整年龄、糖尿病和阻塞性睡眠呼吸暂停后,较低的生理职能和较低的地中海饮食依从性( = 0.001 和 = 0.009)与显著 LF 的风险增加相关。地中海饮食依从性低和生理职能低可能会影响 NAFLD 患者发生显著肝纤维化的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/142f/10346905/fc83548da98c/nutrients-15-03018-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/142f/10346905/fc83548da98c/nutrients-15-03018-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/142f/10346905/fc83548da98c/nutrients-15-03018-g001.jpg

相似文献

1
Impact of Health Related QoL and Mediterranean Diet on Liver Fibrosis in Patients with NAFLD.非酒精性脂肪性肝病患者的健康相关生活质量和地中海饮食对肝纤维化的影响。
Nutrients. 2023 Jul 2;15(13):3018. doi: 10.3390/nu15133018.
2
Impact of Chronotype and Mediterranean Diet on the Risk of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.时型和地中海饮食对非酒精性脂肪性肝病患者肝纤维化风险的影响。
Nutrients. 2023 Jul 23;15(14):3257. doi: 10.3390/nu15143257.
3
Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.基于地中海生活方式的干预对非酒精性脂肪性肝病患者临床特征的改善:一项随机对照临床试验。
Br J Nutr. 2018 Jul;120(2):164-175. doi: 10.1017/S000711451800137X.
4
Higher liver stiffness scores are associated with early kidney dysfunction in patients with histologically proven non-cirrhotic NAFLD.肝硬度评分升高与组织学证实的非肝硬化性 NAFLD 患者早期肾功能障碍相关。
Diabetes Metab. 2020 Sep;46(4):288-295. doi: 10.1016/j.diabet.2019.11.003. Epub 2019 Nov 28.
5
Usefulness of controlled attenuation parameter and liver stiffness measurement for detecting increased arterial stiffness in asymptomatic populations in China.在中国无症状人群中,受控衰减参数和肝脏硬度测量对于检测动脉僵硬度增加的有用性。
Medicine (Baltimore). 2020 Nov 25;99(48):e23360. doi: 10.1097/MD.0000000000023360.
6
Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients.代谢综合征、非酒精性脂肪性肝病与银屑病关节炎及银屑病患者的肝硬度。
Clin Rheumatol. 2019 Oct;38(10):2843-2850. doi: 10.1007/s10067-019-04646-7. Epub 2019 Jun 28.
7
Impact of a Mediterranean diet on hepatic and metabolic outcomes in non-alcoholic fatty liver disease: The MEDINA randomised controlled trial.地中海饮食对非酒精性脂肪性肝病患者肝脏和代谢结局的影响:MEDINA 随机对照试验。
Liver Int. 2022 Jun;42(6):1308-1322. doi: 10.1111/liv.15264. Epub 2022 Apr 26.
8
Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population.基于瞬时弹性成像技术的非酒精性脂肪性肝病的流行率和严重程度:一般人群中的遗传和代谢危险因素。
Liver Int. 2018 Nov;38(11):2060-2068. doi: 10.1111/liv.13743. Epub 2018 May 7.
9
Comparison of point-shear wave elastography (ElastPQ) and transient elastography (FibroScan) for liver fibrosis staging in patients with non-alcoholic fatty liver disease.对比点剪切波弹性成像(ElastPQ)和瞬时弹性成像(FibroScan)在非酒精性脂肪性肝病患者肝纤维化分期中的应用。
Liver Int. 2022 Oct;42(10):2195-2203. doi: 10.1111/liv.15297. Epub 2022 Jun 15.
10
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study. FibroScan-AST (FAST) 评分用于无创识别有显著活动度和纤维化的非酒精性脂肪性肝炎患者:一项前瞻性推导和全球验证研究。
Lancet Gastroenterol Hepatol. 2020 Apr;5(4):362-373. doi: 10.1016/S2468-1253(19)30383-8. Epub 2020 Feb 3.

引用本文的文献

1
Effect of anti-inflammatory diets on health-related quality of life in adults with chronic disease: a systematic review and meta-analysis.抗炎饮食对慢性病成年人健康相关生活质量的影响:一项系统评价和荟萃分析。
BMJ Nutr Prev Health. 2025 Jun 10;8(1):e001257. doi: 10.1136/bmjnph-2025-001257. eCollection 2025.
2
NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic-Metabolic Interplay.非酒精性脂肪性肝病纤维化进展与2型糖尿病:肝脏-代谢相互作用
Life (Basel). 2024 Feb 18;14(2):272. doi: 10.3390/life14020272.
3
Lifestyle and Quality of Life of Women Diagnosed with Hypothyroidism in the Context of Non-Alcoholic Fatty Liver.

本文引用的文献

1
Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者死亡的原因和风险概况。
Clin Mol Hepatol. 2023 Feb;29(Suppl):S43-S57. doi: 10.3350/cmh.2022.0351. Epub 2022 Nov 22.
2
Vitality, mental health and role-physical mediate the influence of coping on depressive symptoms and self-efficacy in patients with non-alcoholic fatty liver disease: A cross-sectional study.活力、心理健康和角色身体功能介导应对方式对非酒精性脂肪性肝病患者抑郁症状和自我效能感的影响:一项横断面研究。
J Psychosom Res. 2022 Nov;162:111045. doi: 10.1016/j.jpsychores.2022.111045. Epub 2022 Sep 21.
3
非酒精性脂肪性肝病背景下被诊断为甲状腺功能减退的女性的生活方式与生活质量
Metabolites. 2023 Nov 26;13(12):1174. doi: 10.3390/metabo13121174.
The effectiveness and acceptability of Mediterranean diet and calorie restriction in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis.
地中海饮食和热量限制对非酒精性脂肪性肝病(NAFLD)的有效性和可接受性:系统评价和荟萃分析。
Clin Nutr. 2022 Sep;41(9):1913-1931. doi: 10.1016/j.clnu.2022.06.037. Epub 2022 Jul 2.
4
Role of NAFLD on the Health Related QoL Response to Lifestyle in Patients With Metabolic Syndrome: The PREDIMED Plus Cohort.非酒精性脂肪性肝病对代谢综合征患者生活方式与健康相关生活质量反应的作用:PREDIMED 加队列研究。
Front Endocrinol (Lausanne). 2022 Jun 29;13:868795. doi: 10.3389/fendo.2022.868795. eCollection 2022.
5
Diagnostic scores and scales for appraising Nonalcoholic fatty liver disease and omics perspectives for precision medicine.用于评估非酒精性脂肪性肝病的诊断评分和量表,以及精准医学的组学视角。
Curr Opin Clin Nutr Metab Care. 2022 Sep 1;25(5):285-291. doi: 10.1097/MCO.0000000000000849. Epub 2022 Jul 5.
6
Fatigue in Cirrhosis.肝硬化中的疲劳
J Clin Exp Hepatol. 2022 Mar-Apr;12(2):617-624. doi: 10.1016/j.jceh.2021.08.028. Epub 2021 Sep 4.
7
Non-Alcoholic Fatty Liver Disease (NAFLD) and Potential Links to Depression, Anxiety, and Chronic Stress.非酒精性脂肪性肝病(NAFLD)及其与抑郁症、焦虑症和慢性应激的潜在联系。
Biomedicines. 2021 Nov 16;9(11):1697. doi: 10.3390/biomedicines9111697.
8
Quality of life and unmet needs in patients with chronic liver disease: A mixed-method systematic review.慢性肝病患者的生活质量与未满足的需求:一项混合方法的系统评价。
JHEP Rep. 2021 Sep 28;3(6):100370. doi: 10.1016/j.jhepr.2021.100370. eCollection 2021 Dec.
9
Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry.全球非酒精性脂肪性肝病(NASH)/非酒精性脂肪性肝病(NAFLD)患者的临床和患者报告结局:来自全球非酒精性脂肪性肝炎(NASH)/非酒精性脂肪性肝病(NAFLD)注册中心的数据。
Clin Gastroenterol Hepatol. 2022 Oct;20(10):2296-2306.e6. doi: 10.1016/j.cgh.2021.11.004. Epub 2021 Nov 9.
10
Sleep and liver disease: a bidirectional relationship.睡眠与肝脏疾病:双向关系。
Lancet Gastroenterol Hepatol. 2021 Oct;6(10):850-863. doi: 10.1016/S2468-1253(21)00169-2. Epub 2021 Jul 15.